Indications and uses
temporarily relieves minor aches and pains due to: the common cold headache backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever
temporarily relieves minor aches and pains due to: the common cold headache backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever
do not take more than directed (see overdose warning) adults and children 12 years and over take 2 caplets every 6 hours while symptoms last do not take more than 6 caplets in 24 hours, unless directed by a doctor do not use for more than 10 days unless directed by a doctor children under 12 years ask a doctor
Acetaminophen 500 mg
Pain reliever/fever reducer
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take
Allergy alert: acetaminophen may cause severe skin reactions. Symptoms may include:
If a skin reaction occurs, stop use and seek medical help right away.
liver disease.
taking the blood thinning drug warfarin.
These could be signs of a serious condition.
ask a health professional before use.
Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
adults and children 12 years and over |
|
children under 12 years | ask a doctor |
hypromellose, povidone, pregelatinized corn starch, sodium starch glycolate, stearic acid, talc, triacetin
(866) 562-2756 (Mon - Fri 8 AM to 4 PM EST)
PHARBEST
NDC 73057-350-11
Manufactured in the USA
Extra Strength *Compare to the active ingredient in Extra Strength Tylenol ® Caplet
Contains no Aspirin
PHARBETOL
Acetaminophen 500 mg each
Pain Reliever/Fever Reducer
1000 CAPLETS
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 198440 | acetaminophen 500 MG Oral Tablet | PSN | 3 |
| 1293942 | Pharbetol 500 MG Oral Tablet | PSN | 3 |
| 1293942 | acetaminophen 500 MG Oral Tablet [Pharbetol] | SBD | 3 |
| 198440 | acetaminophen 500 MG Oral Tablet | SCD | 3 |
| 198440 | APAP 500 MG Oral Tablet | SY | 3 |
| 1293942 | APAP 500 MG Oral Tablet [Pharbetol] | SY | 3 |
| 1293942 | Pharbetol 500 MG Oral Tablet | SY | 3 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 73057-350-08 | 2022-01-31 | C162847 | 48780-1 | d6a99b39-9ea0-a426-e053-dadaa90af4c2 | Drug Facts |
| 73057-350-11 | 2022-01-31 | C162847 | 48780-1 | d6a99b39-9ea0-a426-e053-dadaa90af4c2 | Drug Facts |
| 73057-350-08 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-9ea0-a426-e053-dadaa90af4c2 | Drug Facts |
| 73057-350-11 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-9ea0-a426-e053-dadaa90af4c2 | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73057-350-08 | Pharbetol | 100 in 1 BOTTLE, PLASTIC | TABLET, COATED | 100 | 3 | |
| 73057-350-11 | Pharbetol | 1000 in 1 BOTTLE, PLASTIC | TABLET, COATED | 1000 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 73057-350 | 73057-350-11, 73057-350-08 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| POVIDONE, UNSPECIFIED | FZ989GH94E | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| SODIUM STARCH GLYCOLATE TYPE A CORN | AG9B65PV6B | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| TALC | 7SEV7J4R1U | IACT |
| TRIACETIN | XHX3C3X673 | IACT |
| ACETAMINOPHEN | 362O9ITL9D | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pharbetol | ACETAMINOPHEN 500MG | Ulai Health LLC | c9d3cee1-531c-439f-ae19-07acd366aad6 | 2025-01-20 | Warnings | 73057-350-08 73057-350-11 73057-350 73057035008 73057035011 2c2a6b82-dd55-8cf9-e063-6294a90a68f7 c9d3cee1-531c-439f-ae19-07acd366aad6 |
Adverse event summaries are temporarily unavailable. Other product information remains available.